4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-015778
CHIEF FINANCIAL OFFICER sold 18,299 shares at $28.80 ($527,011)
- CHIEF FINANCIAL OFFICER acquired 18,299 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-06-03 | Option exercise 10b5-1 | +18,299 | $18.00 | $329,382 | 45,308 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-06-03 | Sale 10b5-1 | −18,299 | $28.80 | $527,011 | 27,009 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-06-03 | Option exercise · Share Option 10b5-1 | −18,299 | 0 | D | ||
| Open-market sales · 18,299 sh · avg $28.80 · $527,011 | |||||||
Loading xslF345X05/form4-06052025_080632.xml…